Literature DB >> 18926821

Elucidating the phenomenon of HESC-derived RPE: anatomy of cell genesis, expansion and retinal transplantation.

Anthony Vugler1, Amanda-Jayne Carr, Jean Lawrence, Li Li Chen, Kelly Burrell, Andrew Wright, Peter Lundh, Ma'ayan Semo, Ahmad Ahmado, Carlos Gias, Lyndon da Cruz, Harry Moore, Peter Andrews, James Walsh, Peter Coffey.   

Abstract

Healthy Retinal Pigment Epithelium (RPE) cells are required for proper visual function and the phenomenon of RPE derivation from Human Embryonic Stem Cells (HESC) holds great potential for the treatment of retinal diseases. However, little is known about formation, expansion and expression profile of RPE-like cells derived from HESC (HESC-RPE). By studying the genesis of pigmented foci we identified OTX1/2-positive cell types as potential HESC-RPE precursors. When pigmented foci were excised from culture, HESC-RPE expanded to form extensive monolayers, with pigmented cells at the leading edge assuming a precursor role: de-pigmenting, proliferating, expressing keratin 8 and subsequently re-differentiating. As they expanded and differentiated in vitro, HESC-RPE expressed markers of both developing and mature RPE cells which included OTX1/2, Pax6, PMEL17 and at low levels, RPE65. In vitro, without signals from a developing retinal environment, HESC-RPE could produce regular, polarised monolayers with developmentally important apical and basal features. Following transplantation of HESC-RPE into the degenerating retinal environment of Royal College of Surgeons (RCS) dystrophic rats, the cells survived in the subretinal space, where they maintained low levels of RPE65 expression and remained out of the cell cycle. The HESC-RPE cells responded to the in vivo environment by downregulating Pax6, while maintaining expression of other markers. The presence of rhodopsin-positive material within grafted HESC-RPE indicates that in the future, homogenous transplants of this cell type may be capable of supporting visual function following retinal dystrophy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18926821     DOI: 10.1016/j.expneurol.2008.09.007

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  120 in total

Review 1.  Stemming vision loss with stem cells.

Authors:  Valentina Marchetti; Tim U Krohne; David F Friedlander; Martin Friedlander
Journal:  J Clin Invest       Date:  2010-09-01       Impact factor: 14.808

Review 2.  Retinal pigment epithelium differentiation of stem cells: current status and challenges.

Authors:  Basak E Uygun; Nripen Sharma; Martin Yarmush
Journal:  Crit Rev Biomed Eng       Date:  2009

Review 3.  Cell replacement and visual restoration by retinal sheet transplants.

Authors:  Magdalene J Seiler; Robert B Aramant
Journal:  Prog Retin Eye Res       Date:  2012-07-05       Impact factor: 21.198

Review 4.  Progressing a human embryonic stem-cell-based regenerative medicine therapy towards the clinic.

Authors:  Paul Whiting; Julie Kerby; Peter Coffey; Lyndon da Cruz; Ruth McKernan
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-10-19       Impact factor: 6.237

Review 5.  Studying melanin and lipofuscin in RPE cell culture models.

Authors:  Michael E Boulton
Journal:  Exp Eye Res       Date:  2014-09       Impact factor: 3.467

Review 6.  Stem cell therapies for retinal diseases: recapitulating development to replace degenerated cells.

Authors:  Cuiping Zhao; Qingjie Wang; Sally Temple
Journal:  Development       Date:  2017-04-15       Impact factor: 6.868

7.  Generation of retinal pigment epithelial cells from small molecules and OCT4 reprogrammed human induced pluripotent stem cells.

Authors:  Tim U Krohne; Peter D Westenskow; Toshihide Kurihara; David F Friedlander; Mandy Lehmann; Alison L Dorsey; Wenlin Li; Saiyong Zhu; Andrew Schultz; Junhua Wang; Gary Siuzdak; Sheng Ding; Martin Friedlander
Journal:  Stem Cells Transl Med       Date:  2012-02       Impact factor: 6.940

8.  Structure and barrier properties of human embryonic stem cell-derived retinal pigment epithelial cells are affected by extracellular matrix protein coating.

Authors:  Anni Sorkio; Heidi Hongisto; Kai Kaarniranta; Hannu Uusitalo; Kati Juuti-Uusitalo; Heli Skottman
Journal:  Tissue Eng Part A       Date:  2014-01-20       Impact factor: 3.845

9.  Phase 1 clinical study of an embryonic stem cell-derived retinal pigment epithelium patch in age-related macular degeneration.

Authors:  Lyndon da Cruz; Kate Fynes; Odysseas Georgiadis; Julie Kerby; Yvonne H Luo; Ahmad Ahmado; Amanda Vernon; Julie T Daniels; Britta Nommiste; Shazeen M Hasan; Sakina B Gooljar; Amanda-Jayne F Carr; Anthony Vugler; Conor M Ramsden; Magda Bictash; Mike Fenster; Juliette Steer; Tricia Harbinson; Anna Wilbrey; Adnan Tufail; Gang Feng; Mark Whitlock; Anthony G Robson; Graham E Holder; Mandeep S Sagoo; Peter T Loudon; Paul Whiting; Peter J Coffey
Journal:  Nat Biotechnol       Date:  2018-03-19       Impact factor: 54.908

10.  A simple and scalable process for the differentiation of retinal pigment epithelium from human pluripotent stem cells.

Authors:  Julien Maruotti; Karl Wahlin; David Gorrell; Imran Bhutto; Gerard Lutty; Donald J Zack
Journal:  Stem Cells Transl Med       Date:  2013-04-12       Impact factor: 6.940

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.